sur BASTIDE (EPA:BLC)
The Bastide Group sells EXPERF to Sapio Group
The Bastide Group has reached an agreement to sell its subsidiary New Medical Concept, the holding company of EXPERF, to Sapio Group. Specializing in home infusion and nutrition, EXPERF has doubled its revenue since its acquisition by Bastide in 2017.
Revenue increased from €18 million to €42 million for the 2024-2025 financial year. This sale is part of the Bastide Group's debt reduction strategy, allowing it to improve its financial leverage ratio after the transaction, which is expected to have no impact on 2026 revenue.
Sapio, leveraging EXPERF's network in France, aims to strengthen its position in Europe. The completion of the transaction remains subject to customary closing conditions.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BASTIDE